NCT07742020Recruiting
Neurodevelopmental Technique Versus Mirror Therapy in Sub-acute Stroke Patients
Effects of Neurodevelopmental Technique Versus Mirror Therapy on Coordination, Functions and Ambulation in Sub-acute Hemiplegic Stroke Patients
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
As neurodevelopmental technique and mirror therapy had different effects on lower limb coordination, functions and ambulation. Both had proven to be helpful in the stroke patients to gain functional independency. Therefore, there was need to find out the best treatment approach either NDT, mirror therapy or both are equally effective to improve motor functions, coordination and ambulation of lower limb. This study would provide the health professionals the evidence to use best technique among these according to improvement in patients' coordination, function and ambulation.The study will be randomized clinical trial. This study will be conducted at the University of Lahore. A sample size of 40 will be randomly allocated by into two experimentals groups, (20 participants in each group), by the lottery method. All the screened and willing participants will be randomly allocated to two groups (Group A: Experimental group Neurodevelopmental technique, Group B: Experimental Group mirror therapy exercise) by lottery method. This study will be a single blinded study in which assessor will be blinded.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 11 Sept 2025
- Start date
- 8 Sept 2025
- Primary completion date
- 30 Jul 2026
- Lead sponsor
- University of Lahore
- Diseases
- Stroke
- NCT number
- NCT07742020
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 8 Sept 2025 to the primary completion date, 30 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients had recurrent stroke.
- Any systemic conditions that limit functions such as; cardiac diseases (exertional dyspnea, angina, Myocardial Infarction, Pacemaker) Pulmonary diseases (Asthma, Pulmonary Fibrosis etc.), Diabatic neuropathy, Diabetic foot, Varicose veins etc
- Other neurological conditions, such as; foot drop, muscular dystrophy, Myasthenia Gravis, Parkinsonism
- Any surgical and traumatic history of fractures, dislocations and/or brain injury due to any traumatic events.
Other
- Any visual and hearing problem
Who the study is looking for
- Age range between 45 to 65 years
- Both genders
- Sub-acute stroke hemiplegic cases; clinically stable, fully oriented and conscious.
- Both ischemic and hemorrhagic patients were be included.
- Patients with mini mental status examination (MMSE) (score \> 23)
Age in the registry: 45 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of lahore teaching hospital Coordinator of this site? Confirm its status | Lahore | Pakistan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.